All Episodes
PETRI DISH PERSPECTIVES — 60 episodes
Episode 54: All about 340B
April 2026: Biotech & Pharma NEWS Roundup
Episode 53: CAR-T Therapies
Episode 52: Daiichi Sankyo
Episode 51: ImmunoGen
Episode 50: Exact Sciences
Episode 49: AI in Pharma / Biotech
March 2026: Biotech & Pharma NEWS Roundup
Episode 48: Ginkgo Bioworks
Episode 47: SUN Pharma
Episode 46: Servier
Episode 45: BioMarin
February 2026: Biotech & Pharma NEWS Roundup
Episode 44: BioNTech
Episode 43: ARCH Venture Partners
Episode 42: Otsuka
Episode 41: Gene Therapies
January 2026: Biotech & Pharma NEWS Roundup
Episode 40: Eisai
Episode 39: Flagship Pioneering
Episode 38: Biogen
Episode 37: Theranos
Episode 36: Novo Nordisk
December 2025: Biotech & Pharma NEWS Roundup
Episode 35: Dyes to Pharma
Episode 34: Astellas
Episode 33: Novartis
Episode 32: Recursion
November 2025: Biotech & Pharma NEWS Roundup
Episode 31: Bispecific Antibodies
Episode 30: Metsera
Episode 29: Charles River Laboratories
Episode 28: Regeneron
Episode 27: Tempus AI
Episode 26: Wuxi AppTec
Episode 25: CVS Health
Episode 24: GLP-1 Agonists
Episode 23: Alnylam
Episode 22: Takeda
Episode 21: Moderna
Episode 20: Baxter
Episode 19: AstraZeneca
Episode 18: Gilead
Episode 17: GSK
Episode 16: Amgen
Episode 15: BGI Genomics
Episode 14: Abbott
Episode 13: Sarepta
Episode 12: Vertex
Episode 11: Genentech
Episode 10: Roche
Episode 9: Bayer
Episode 8: Bristol Myers Squibb
Episode 7: Sanofi
Episode 6: Merck
Episode 5: Boehringer Ingelheim
Episode 4: Johnson & Johnson
Episode 3: AbbVie
Episode 2: Eli Lilly
Episode 1: Pfizer